(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,Z)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one; Clarithromycin (9Z)-Oxime; -O-Methylerythromycin (9Z)-9-Oxime; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,Z)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one; Clarithromycin EP Impurity L
Clarithromycin EP Impurity L is a fully characterized chemical compound used as a reference standard of API Clarithromycin. The standard offered is compliant with regulatory guidelines. Clarithromycin EP Impurity L is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 127253-05-8
Related products
Clarithromycin EP Impurity D (N-Desmethyl Clarithromycin)
M.F.
M.W. 733.94
CAT# AR-C03024
CAS# 101666-68-6
Clarithromycin EP Impurity G (Mixture of Z and E Isomers)
M.F.
M.W. 777.01
CAT# AR-E00998
CAS# 107216-09-1
N-(3-Desethynylphenyl)-N-(3-bromophenyl) Erlotinib Hydrochloride
M.F.
M.W. 448.31 36.5
CAT# AR-E02315
CAS# 2055840-41-8
